Purchase Order 75N92025P00061
Award Date
2/1/25
Potential Completion Date
1/31/26
Potential Value
$42K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $64,908 firm fixed price purchase order to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for maintenance services for the CantoiI flow cytometer analyzer. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide maintenance services for the flow cytometer located in Bethesda, Maryland...
This is a $51,828.84 firm-fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance of Fortessa flow cytometer analyzers. The contract has a period of performance through January 12, 2026. BD is a global medical technology company that provides a range of biomedical research and clinical instruments, including flow cytometers, as well as...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Becton, Dickinson And Company (BD) on January 10, 2020 for the maintenance of a BD Fortessa flow cytometer analyzer. The contract has a potential value of $223,064.40 and a completion date of January 12, 2025. The place of performance is Bethesda, Maryland. BD is a global medical technology company that provides a...
This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...
This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on the LSR Fortessa equipment located in the NHLBI Division of Intramural Research (DIR). The contract has a period of performance of one year with four optional one-year extension periods, for a total potential value of $203,688. The contract does not have a set-aside...
This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...
This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...
This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
This is a delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) under the company's Multiple Award Schedule (MAS) contract. The $43,416.72 firm-fixed-price order is for a cytometer service contract to support ongoing experimental analyses for multiple NHLBI projects in the Basic and Translational Immunology Section. The award has no set-aside designation and the contract period of...